Hyliion Holdings Corp. current report, 01 October 2020

Full document

Hyliion Holdings Corp. Form 8-K Summary

Business context and reporting period

Filed October 7, 2020, reporting events occurring primarily on October 1, 2020. Hyliion Holdings Corp. completed its business combination with Legacy Hyliion through the merger of a wholly owned subsidiary with Legacy Hyliion. Tortoise Acquisition Corp. changed its name to Hyliion Holdings Corp. and ceased to be a shell company.

After closing, Hyliion Holdings became a holding company whose principal asset was its equity interest in Legacy Hyliion. Its common stock and warrants began trading on the NYSE under the symbols HYLN and HYLN WS, respectively.

Key financial and capitalization metrics

  • PIPE financing: 30,750,000 common shares sold at $10.00 per share for aggregate proceeds of $307.5 million.
  • Forward purchase transaction: Atlas Point Fund purchased 1,750,000 units for $17.5 million, consisting of 1,750,000 common shares and warrants to purchase 875,000 shares. Atlas Point transferred 894,375 shares to TortoiseEcofin Borrower LLC.
  • Post-closing capitalization: approximately 153,901,829 common shares outstanding and 19,185,641 warrants outstanding. Each warrant was exercisable for one share at $11.50.
  • The filing does not provide clear post-closing revenue, profit, cash-flow, margin, debt, or liquidity balances. Historical and pro forma financial statements are incorporated by reference from the proxy statement.
  • No cash dividends had been paid, and management did not anticipate declaring dividends in the foreseeable future.

Material changes versus the prior comparable period

  • The transaction transformed the registrant from a special purpose acquisition company with no operations into the public holding company for Legacy Hyliion.
  • Legacy Hyliion preferred stock and convertible notes, including accrued interest, converted into Legacy Hyliion common stock before the merger. Legacy convertible notes and related liens were extinguished.
  • Each Legacy Hyliion common share converted into 1.45720232 shares of Hyliion Holdings common stock.
  • Legacy Hyliion options were converted into options to purchase Hyliion Holdings common stock, with adjusted share amounts and exercise prices.
  • The board increased from five to seven directors, and Thomas Healy became Chief Executive Officer, Greg Van de Vere became Chief Financial Officer, and Patrick Sexton became Chief Technology Officer.
  • Grant Thornton LLP replaced WithumSmith+Brown, PC as the independent registered public accounting firm for the post-combination company. The filing reports no disagreements or reportable events involving Withum.

Guidance, outlook, risks, contingencies, and unusual items

  • The filing contains no specific revenue, earnings, production, or cash-burn guidance.
  • Management’s forward-looking statements depend on realizing the anticipated benefits of the combination, obtaining customer orders, converting early fleet trials into meaningful deployments, scaling production cost-effectively, and achieving market acceptance of hybrid and fully electric trucks.
  • The Agility Logistics pre-order is subject to testing and performance requirements, termination rights, and potential enforceability challenges.
  • Other material risks include competition, commercialization and funding needs, future capital requirements, COVID-19 effects, regulatory changes, legal proceedings, intellectual-property protection, partnership execution, and the ability to address the targeted market.
  • Legacy holders generally agreed to 180-day lock-ups. Thomas Healy agreed not to transfer more than 10% of specified holdings until two years after closing, subject to stated exceptions.
  • Directors and executive officers entered into indemnification agreements covering specified expenses, including legal fees, judgments, fines, and settlements arising from their service.

Most important facts for investors to verify

  1. Review the proxy statement and incorporated financial statements for Legacy Hyliion’s historical revenue, losses, cash flows, debt, liquidity, and pro forma capitalization.
  2. Reconcile the $307.5 million PIPE proceeds and $17.5 million forward purchase proceeds to the post-closing balance sheet and transaction expenses.
  3. Assess dilution from approximately 19.2 million outstanding warrants, converted options, and other equity awards.
  4. Evaluate the commercial status, testing requirements, and termination provisions of the Agility Logistics pre-order and other customer or collaboration arrangements.
  5. Review the lock-up, registration-rights, related-party, indemnification, and equity incentive-plan provisions.
  6. Monitor whether Hyliion requires additional capital before commercialization and production, as the filing identifies future funding needs but does not provide a clear liquidity runway.